Skip to content

Fetal Imaging

Developing novel prenatal imaging techniques to visualise blood circulation and location of organs, and detect anomalies with higher accuracy

What does this
Theme Involve?

Maternal and Fetal Medicine research has a long established track record at UCL, pioneering many new therapies which are now common treatment practices. This theme represents a significant collaboration of scientists and clinicians with a unifying aim to improve outcomes for pregnant women and their babies through improved diagnosis and treatment.

There are still a number key unmet clinical needs in this area, which are influenced by the added complications of fetal medicine and the ethical considerations needed. Current imaging techniques need improvement to deal with specific issues, such as cloudy amniotic fluids, and advanced tools are needed to deliver any new therapies without posing a high risk to the mother and unborn child. This theme offers students a real opportunity to develop and influence clinical practice and offer world-firsts in new treatment possibilities.

Partners and Facilities

This theme works closely with the Institute for Women’s Health, the Fetal Medicine Unit at UCLH and KU Leuven (Belgium), providing the student access to the staff and expertise these partners can offer. Unique facilities under this theme include advanced fetoscopic devices and new surgical planning software.

Studying Under this theme

Projects listed below are available for applicants to include in their 5 project choices. Successful candidates will meet with both primary supervisors from their selection as part of the induction process before being assigned to an allocated research project. To view all available project videos please visit our YouTube channel.

Theme Leader

Dr Anna David
UCL Institute for Women's Health

Dr David obtained a PhD on clinically applicable methods of delivering fetal gene therapy in 2005 at UCL and the group was established in 2007. The unifying aim of the research is to develop prenatal treatment of severe and life-threatening disorders using gene and cellular therapy, and to investigate the efficacy, safety and ethical issues of such treatment. This work is internationally competitive and only a few groups in the world are working in the area.